Clinical Trial Update: AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating azelastine/fluticasone nasal spray for symptom control, nasal mediators, and nasal hyperresponsiveness in allergic rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• House Dust Mite Allergy

Drugs mentioned

• DYMISTA (azelastine hydrochloride and fluticasone propionate)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Allergic Rhinitis, House Dust Mite Allergy | Phase 4 | Status: UNKNOWN